期刊文献+

胰岛素对初诊2型糖尿病患者的疗效观察 被引量:1

下载PDF
导出
摘要 目的探讨短期胰岛素强化治疗对初诊2型糖尿病患者的降糖效果及其对胰岛β细胞功能的影响。方法选用79例初诊为2型糖尿病的患者,按自愿的原则分为胰岛素泵组(CSII组,40例)和多次皮下注射胰岛素组(MSII组,39例),进行两周的胰岛素强化治疗,比较两组空腹及餐后血糖下降速度、程度,所需胰岛素剂量,发生低血糖事件及胰岛β细胞功能改善程度的差异。结果在强化治疗第2天,CSII组早、晚餐后2h血糖即明显低于MSII组,第7天CSII组空腹和午餐后2h血糖降低程度也明显大于MSII组。治疗第14天,则只有空腹血糖存在差异;停止治疗后,空腹和早晚餐后2h血糖在两组间差异仍有统计学意义。CSII组获理想血糖控制时间短于MSII组(48h比144h)所需胰岛素剂量又较小(0.6u/kg比0.8u/kg)。强化治疗前后胰岛β细胞功能如口服葡萄糖耐量试验中胰岛素和C肽曲线下的面积、Homa-β、Homa-IR在两组间差异无统计学意义。治疗中两组仅见轻度低血糖事件:CSII组2例次(5%),MSII组9例次(23%)。结论短期胰岛素强化治疗能改善胰岛β细胞功能,减轻胰岛素抵抗,CSII较MSII更适合作为强化治疗手段。
出处 《中国现代医生》 2010年第1期20-21,23,共3页 China Modern Doctor
  • 相关文献

参考文献5

二级参考文献27

  • 1Purrello F, Rabuazza AM. Metabolic factors that affect betacell function and survival. Diabet Nutr Metab, 2000, 13: 84-91.
  • 2Sivitz WI. Lipotoxieity and glueotoxieity in type 2 diabetes. Effects on development and progression. Postgrad Med, 2001,109: 55-59,63-64.
  • 3Lenhard M J, Reeves GD. Continous subcutaneous insulin infusion: a comprehensive review of insulin pump therapy. Arch Intern Med,2001,161: 2293-2300.
  • 4Dupuy O, Mayaudon H, Palou M, et al. Optimized transient insulin infusion in uneontrolled type 2 Diabetes : Evaluation of a pragmatie attitude. Diabet Med, 2000,26 : 371-375.
  • 5Valensi P, Moura I, Magoarou M,et al. Short-term effects of continuous subcutaneous insulin infusion treatment on insulin secretion in non-insulin-dependent overweight patients with poor glycaemic control despite maximal oral anti-diabetic treatment. Diabet Metab,1997,23: 51-57.
  • 6Lormeau B, Aurousseau MH, Valensi P, et al. Hyperinsulinemia and hypofibrinolysis: effects of short-term optimized glyeemic control with contineuous insulin infusion in type Ⅱ diabetie patients. Metabolism,1997,46: 1074-1079.
  • 7Ilkova H, Glaser B, Tunckale A, et al. Induction of long-term glycemic control in newly diagnosed type 2 diabetic patients by transient intensive insulin treatment. Diabetes Care, 1997,20:1353-1356.
  • 8Pratley RE, Weyer C. The role of impaired early insulin secretion in the pathogenesis of type II diabetes mellitus. Diabetologia 2001,44:929-945.
  • 9Del Prato S, Marchetti P, Bonadonna RC. Phasic insulin release and metabolic regulation in type 2 diabetes. Diabetes,2002, 51suppl 1: s109-116.
  • 10Kahn SE. The importance of the beta-cell in the pathogenesis of type 2 diabetes mellitus. Am J Med, 2000,108suppl 6a: 2s-8s.

共引文献1088

同被引文献21

引证文献1

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部